We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$17.4B
AUM Growth
+$604M
Cap. Flow
-$350M
Cap. Flow %
-2.01%
Top 10 Hldgs %
29.23%
Holding
2,926
New
46
Increased
346
Reduced
1,409
Closed
76

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$18.5M
2
PLTR icon
Palantir
PLTR
+$14.9M
3
AVTR icon
Avantor
AVTR
+$8.33M
4
DELL icon
Dell
DELL
+$8.18M
5
AVGO icon
Broadcom
AVGO
+$6.3M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$42.3M
2
NVDA icon
NVIDIA
NVDA
+$24.6M
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$24.5M
4
MSFT icon
Microsoft
MSFT
+$23.9M
5
EFA icon
iShares MSCI EAFE ETF
EFA
+$11.8M

Sector Composition

Rank Sector Weight
1 Technology 29.85%
2 Financials 12.38%
3 Healthcare 11.45%
4 Consumer Discretionary 10.71%
5 Industrials 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHCT
2076
Community Healthcare Trust
CHCT
$433M
$293K ﹤0.01%
16,140
+13
+0.1% +$266
PAHC icon
2077
Phibro Animal Health
PAHC
$1.38B
$293K ﹤0.01%
12,996
– –
NCMI icon
2078
National CineMedia
NCMI
$252M
$292K ﹤0.01%
+41,472
New +$253K
RVNC
2079
DELISTED
Revance Therapeutics, Inc.
RVNC
$292K ﹤0.01%
56,279
+1,010
+2% +$5.02K
RBCAA icon
2080
Republic Bancorp
RBCAA
$1.92B
$292K ﹤0.01%
4,469
-631
-12% -$38.6K
YMAB
2081
DELISTED
Y-mAbs Therapeutics
YMAB
$291K ﹤0.01%
22,141
– –
BFS
2082
Saul Centers
BFS
$865M
$290K ﹤0.01%
6,900
-210
-3% -$8.26K
OLP
2083
One Liberty Properties
OLP
$537M
$289K ﹤0.01%
10,478
-16
-0.2% -$415
CRMD icon
2084
CorMedix
CRMD
$639M
$288K ﹤0.01%
35,639
– –
PGY icon
2085
Pagaya Technologies
PGY
$1.79B
$288K ﹤0.01%
27,232
+16,804
+161% +$221K
BBW icon
2086
Build-A-Bear
BBW
$474M
$287K ﹤0.01%
8,360
– –
IIIV icon
2087
i3 Verticals
IIIV
$325M
$287K ﹤0.01%
13,472
– –
NEWT icon
2088
NewtekOne
NEWT
$378M
$287K ﹤0.01%
23,035
– –
TYRA icon
2089
Tyra Biosciences
TYRA
$1.49B
$287K ﹤0.01%
12,207
– –
MYE icon
2090
Myers Industries
MYE
$1.25B
$287K ﹤0.01%
20,731
– –
TERN
2091
DELISTED
Terns Pharmaceuticals
TERN
$286K ﹤0.01%
34,260
– –
NLOP
2092
Net Lease Office Properties
NLOP
$173M
$286K ﹤0.01%
9,327
+5,000
+116% +$144K
DIN icon
2093
Dine Brands
DIN
$440M
$286K ﹤0.01%
9,144
– –
RGNX icon
2094
Regenxbio
RGNX
$704M
$285K ﹤0.01%
27,189
– –
HUMA icon
2095
Humacyte
HUMA
$148M
$284K ﹤0.01%
52,295
– –
SVRA icon
2096
Savara
SVRA
$1.08B
$284K ﹤0.01%
66,907
+14,883
+29% +$65.7K
LESL icon
2097
Leslie's
LESL
$7.21M
$284K ﹤0.01%
4,486
-717
-14% -$44.2K
CLBK icon
2098
Columbia Financial
CLBK
$1.22B
$283K ﹤0.01%
16,597
– –
ERAS icon
2099
Erasca
ERAS
$6.25B
$283K ﹤0.01%
103,686
+35,355
+52% +$99.6K
OLMA icon
2100
Olema Pharmaceuticals
OLMA
$920M
$283K ﹤0.01%
23,695
– –
82 83
84
85 86

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

MetLife Investment Management's Q3 2024 Portfolio in Review

As of Q3 2024, MetLife Investment Management held 2,926 positions worth $17.4B, up 3.6% from $16.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 4.2%. MetLife Investment Management opened 46 new positions and exited 76, leaving the 2,926-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q3 2024 buy was Smurfit Westrock: 128,702 shares worth $6.36M.
  • MetLife Investment Management added most to Apple in Q3 2024, an estimated $18.5M increase.
  • MetLife Investment Management's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $42.3M.
  • MetLife Investment Management fully exited Diamond Offshore Drilling, Inc. in Q3 2024, selling an estimated $6.15M.
  • MetLife Investment Management's ten largest holdings make up 29% of its $17.4B portfolio in Q3 2024.
  • MetLife Investment Management opened 46 new positions and closed 76 in Q3 2024.
  • MetLife Investment Management's portfolio value rose 3.6% quarter-over-quarter to $17.4B.

Based on MetLife Investment Management's 13F filing for Q3 2024, filed 13 Nov 2024.